PL1848403T3 - Preparaty bioadhezyjne o działaniu miejscowym - Google Patents
Preparaty bioadhezyjne o działaniu miejscowymInfo
- Publication number
- PL1848403T3 PL1848403T3 PL05818337T PL05818337T PL1848403T3 PL 1848403 T3 PL1848403 T3 PL 1848403T3 PL 05818337 T PL05818337 T PL 05818337T PL 05818337 T PL05818337 T PL 05818337T PL 1848403 T3 PL1848403 T3 PL 1848403T3
- Authority
- PL
- Poland
- Prior art keywords
- bioadhesive formulations
- topical bioadhesive
- topical
- formulations
- bioadhesive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0500807A GB0500807D0 (en) | 2005-01-14 | 2005-01-14 | Formulation |
GB0507811A GB0507811D0 (en) | 2005-04-18 | 2005-04-18 | Formulation |
PCT/GB2005/002217 WO2005117830A1 (en) | 2004-06-04 | 2005-06-06 | Liquid depot formulations |
EP05818337A EP1848403B8 (en) | 2005-01-14 | 2005-12-09 | Topical bioadhesive formulations |
PCT/GB2005/004746 WO2006075123A1 (en) | 2005-01-14 | 2005-12-09 | Topical bioadhesive formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1848403T3 true PL1848403T3 (pl) | 2010-09-30 |
Family
ID=35928272
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05818337T PL1848403T3 (pl) | 2005-01-14 | 2005-12-09 | Preparaty bioadhezyjne o działaniu miejscowym |
PL05818606T PL1845942T3 (pl) | 2005-01-14 | 2005-12-09 | Preparaty analogu GnRH |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05818606T PL1845942T3 (pl) | 2005-01-14 | 2005-12-09 | Preparaty analogu GnRH |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1848403B8 (pl) |
JP (2) | JP5144277B2 (pl) |
CA (2) | CA2594718C (pl) |
PL (2) | PL1848403T3 (pl) |
WO (2) | WO2006075125A1 (pl) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9649382B2 (en) | 2005-01-14 | 2017-05-16 | Camurus Ab | Topical bioadhesive formulations |
SI1845942T1 (sl) | 2005-01-14 | 2014-06-30 | Camurus Ab | Gnrh analogne formulacije |
US8871712B2 (en) | 2005-01-14 | 2014-10-28 | Camurus Ab | Somatostatin analogue formulations |
KR101245022B1 (ko) | 2005-01-21 | 2013-03-19 | 카무러스 에이비 | 약제학적 지질 조성물 |
US8546326B2 (en) | 2005-06-06 | 2013-10-01 | Camurus Ab | Glp-1 analogue formulations |
TW200824693A (en) | 2006-08-28 | 2008-06-16 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of clonazepam and methods of use thereof |
EP2121025B1 (en) * | 2007-01-19 | 2016-11-02 | Hananja Ehf | Methods and compositions for the delivery of a therapeutic agent |
US20080275030A1 (en) | 2007-01-19 | 2008-11-06 | Sveinbjorn Gizurarson | Methods and Compositions for the Delivery of a Therapeutic Agent |
US8530463B2 (en) | 2007-05-07 | 2013-09-10 | Hale Biopharma Ventures Llc | Multimodal particulate formulations |
GB0711656D0 (en) * | 2007-06-15 | 2007-07-25 | Camurus Ab | Formulations |
GB0716385D0 (en) * | 2007-08-22 | 2007-10-03 | Camurus Ab | Formulations |
EP2200582B1 (fr) * | 2007-09-12 | 2013-03-20 | Galderma Research & Development | Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant |
ES2528409T3 (es) * | 2007-10-24 | 2015-02-10 | Camurus Ab | Formulaciones de liberación controlada |
US20090258865A1 (en) | 2008-03-28 | 2009-10-15 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
GB0815435D0 (en) | 2008-08-22 | 2008-10-01 | Camurus Ab | Formulations |
EP2165706A1 (en) * | 2008-09-18 | 2010-03-24 | BioAlliance Pharma | Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers. |
SI2451452T1 (sl) * | 2009-07-08 | 2015-12-31 | Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A. | Uporaba benzidamina pri zdravljenju bolezni, odvisnih od p40 |
CA2794280A1 (en) * | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Bioadhesive compositions of local anaesthetics |
US8565020B2 (en) | 2010-04-14 | 2013-10-22 | Kabushiki Kaisha Toshiba | Semiconductor memory device |
PT3284459T (pt) | 2011-04-29 | 2021-03-30 | Moberg Pharma Ab | Composições farmacêuticas que compreendem um anestésico local como bupivacaína para a administração tópica na boca ou garganta |
CN107737100A (zh) | 2011-06-14 | 2018-02-27 | 哈尔生物药投资有限责任公司 | 苯二氮卓组合物的投与 |
KR101494594B1 (ko) | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
US10064960B2 (en) | 2011-11-25 | 2018-09-04 | Danmarks Tekniske Universitet | Formulation of solid nano-sized particles in a gel-forming system |
PE20141297A1 (es) | 2011-12-05 | 2014-10-09 | Camurus Ab | Formulaciones peptidicas robustas de liberacion controlada |
TW201336526A (zh) * | 2012-01-31 | 2013-09-16 | 參天製藥股份有限公司 | 非水性液體組成物 |
ES2834318T3 (es) | 2012-05-25 | 2021-06-17 | Camurus Ab | Formulaciones de agonistas de receptores de la somatostatina |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
PL2877155T3 (pl) * | 2012-07-26 | 2021-05-17 | Camurus Ab | Formulacje opioidowe |
ES2837803T3 (es) * | 2012-07-26 | 2021-07-01 | Camurus Ab | Formulaciones de opioides |
KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
EP3004049B1 (en) | 2013-06-04 | 2018-09-05 | Cellixbio Private Limited | Compositions and methods for the treatment of diabetes and pre-diabetes |
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
WO2015059193A1 (en) * | 2013-10-22 | 2015-04-30 | Medesis Pharma | Organogel formulation and uses thereof |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
WO2016110865A1 (en) | 2015-01-06 | 2016-07-14 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammation and pain |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015101693A1 (es) * | 2013-12-31 | 2015-07-09 | Servicio Andaluz De Salud | Composiciones y preparaciones combinadas para el tratamiento de las algias orofaríngeas |
ES2809458T3 (es) | 2014-07-17 | 2021-03-04 | Pharmaceutical Manufacturing Res Services Inc | Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata |
NZ736131A (en) | 2014-09-26 | 2019-04-26 | Cellix Bio Private Ltd | Compositions and methods for the treatment of epilepsy and neurological disorders |
CA2967908C (en) | 2014-09-29 | 2020-11-17 | Mahesh Kandula | Compositions and methods for the treatment of multiple sclerosis |
JP2017531026A (ja) | 2014-10-20 | 2017-10-19 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 徐放性乱用抑止性液体充填剤形 |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
GB201516554D0 (en) * | 2015-09-18 | 2015-11-04 | Camurus Ab | Controlled-release formulations |
WO2017168435A1 (en) * | 2016-03-31 | 2017-10-05 | Sun Pharma Advanced Research Company Limited | Viscoelastic gel of liraglutide adapted for once-weekly or once bi-weekly administration |
CA3036307A1 (en) * | 2016-09-15 | 2018-03-22 | Camurus Ab | Prostacyclin analogue formulations |
KR102611788B1 (ko) | 2016-09-27 | 2023-12-12 | 카무러스 에이비 | 알킬 암모늄 edta 염을 포함하는 혼합물 및 제형 |
BR102018008324A2 (pt) * | 2018-04-25 | 2019-11-05 | Laboratorios Ferring Ltda | composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico |
KR20220012316A (ko) | 2019-05-29 | 2022-02-03 | 캐머러스 에이비 | 지질-제어 방출 조성물 |
JP2021059680A (ja) * | 2019-10-08 | 2021-04-15 | 花王株式会社 | 液晶組成物 |
US11911499B2 (en) | 2019-11-07 | 2024-02-27 | Resurge Therapeutics, Inc. | System and method for prostate treatment |
WO2022005169A1 (ko) | 2020-06-30 | 2022-01-06 | 주식회사 종근당 | Gnrh 유도체를 포함하는 주사용 조성물 |
JP7092922B1 (ja) | 2021-06-11 | 2022-06-28 | キユーピー株式会社 | 製剤 |
US11602516B1 (en) | 2022-01-29 | 2023-03-14 | Resurge Therapeutics Inc. | Treating benign prostatic hyperplasia |
US11957654B2 (en) | 2022-01-29 | 2024-04-16 | Resurge Therapeutics, Inc. | Treating benign prostatic hyperplasia |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1274026B (it) * | 1994-03-01 | 1997-07-14 | Acraf | Composizione antitosse |
SE518578C2 (sv) * | 1994-06-15 | 2002-10-29 | Gs Dev Ab | Lipidbaserad komposition |
AU702030B2 (en) * | 1995-10-12 | 1999-02-11 | Gs Development Ab | A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
EP0975331A1 (en) * | 1997-04-17 | 2000-02-02 | Dumex-Alpharma A/S | A novel bioadhesive drug delivery system based on liquid crystals |
BE1011899A6 (fr) * | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
JP2001058955A (ja) * | 1999-06-17 | 2001-03-06 | Inst Of Physical & Chemical Res | 生理活性ペプチド徐放性製剤 |
US6936187B2 (en) * | 2001-02-21 | 2005-08-30 | Matthew Lawrence Lynch | Functionalized cubic liquid crystalline phase materials and methods for their preparation and use |
GB0307777D0 (en) * | 2003-04-04 | 2003-05-07 | Medical Res Council | Conjugate compounds |
EP1682091B1 (en) * | 2003-11-07 | 2017-03-29 | Camurus Ab | Compositions of lipids and cationic peptides |
JP4966018B2 (ja) * | 2004-01-23 | 2012-07-04 | カムルス エービー | 三元非ラメラ脂質組成物 |
BRPI0511807C8 (pt) * | 2004-06-04 | 2021-05-25 | Camurus Ab | pré-formulação, processo de formação de uma pré-formulação e uso da mesma |
-
2005
- 2005-12-09 JP JP2007550825A patent/JP5144277B2/ja active Active
- 2005-12-09 CA CA2594718A patent/CA2594718C/en active Active
- 2005-12-09 EP EP05818337A patent/EP1848403B8/en active Active
- 2005-12-09 PL PL05818337T patent/PL1848403T3/pl unknown
- 2005-12-09 EP EP05818606.5A patent/EP1845942B1/en active Active
- 2005-12-09 CA CA2594710A patent/CA2594710C/en active Active
- 2005-12-09 WO PCT/GB2005/004752 patent/WO2006075125A1/en active Application Filing
- 2005-12-09 WO PCT/GB2005/004746 patent/WO2006075123A1/en active Application Filing
- 2005-12-09 PL PL05818606T patent/PL1845942T3/pl unknown
- 2005-12-09 JP JP2007550827A patent/JP5107725B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CA2594710C (en) | 2011-01-25 |
EP1845942B1 (en) | 2014-04-09 |
JP2008526934A (ja) | 2008-07-24 |
JP5144277B2 (ja) | 2013-02-13 |
WO2006075125A1 (en) | 2006-07-20 |
EP1848403A1 (en) | 2007-10-31 |
PL1845942T3 (pl) | 2014-07-31 |
EP1848403B1 (en) | 2010-03-31 |
WO2006075123A1 (en) | 2006-07-20 |
JP5107725B2 (ja) | 2012-12-26 |
CA2594710A1 (en) | 2006-07-20 |
CA2594718C (en) | 2012-01-24 |
EP1848403B8 (en) | 2010-05-19 |
JP2008526932A (ja) | 2008-07-24 |
EP1845942A1 (en) | 2007-10-24 |
CA2594718A1 (en) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1848403T3 (pl) | Preparaty bioadhezyjne o działaniu miejscowym | |
IL187893A0 (en) | Topical ungual formulations | |
GB0518769D0 (en) | Topical formulations | |
GB2424581B (en) | Formulations | |
GB0424891D0 (en) | Topical compositions | |
GB0524962D0 (en) | Topical pharmaceutical compositions | |
EP1909584A4 (en) | PRENYLFLAVONOID FORMULATIONS | |
IL189856A0 (en) | New formulation | |
TWI370115B (en) | New formulation | |
GB0507208D0 (en) | Anti-inflammatory formulation | |
IL185531A0 (en) | Topical gel compositions | |
PL1888024T3 (pl) | Preparat miejscowy | |
IL185773A0 (en) | Formulations | |
EP1951693A4 (en) | SOLID FORMULATIONS | |
EP1859834A4 (en) | Anti-inflammatory agent | |
EP1957080A4 (en) | TOPICAL GLUCOCORTICOSTEROID FORMULATIONS | |
ZA200707375B (en) | Topical gel compositions | |
EP1895843A4 (en) | MICOGEL TOPICAL FORMULAS | |
EP1750721A4 (en) | TOPICAL FORMULATIONS BASED ON CROMOGLYCIC ACID | |
GB0516558D0 (en) | Topical compositions | |
GB0509123D0 (en) | Topical compositions | |
GB0517519D0 (en) | Topical prostaglandin formulation | |
GB0522917D0 (en) | Formulations | |
GB0518878D0 (en) | Formulations | |
GB0520388D0 (en) | Formulations |